Highest EBITDA
legend_toggleExplore a diverse array of industries, each represented by companies that have excelled in generating substantial EBITDA.
| name | Price | $ Change | % Change | Market Cap | Volume | Avg. Volume | arrow_downwardEBITDA | Technicals | Dividend Y | ROI 1Y | Score language | Last 7 Days | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ATMV ATMVUAlphaVest Acquisition | $10.25 | $10.25 | 0.00% | $0.00 | 0.00 | 0.00 | $0.00 | Sellkeyboard_arrow_down | - | -4.82% | AI Analysis | |||||
LIXT LIXTWLixte Biotechnology Holdings | $0.02 | $0.02 | 0.00% | $0.00 | 300.00 | 0.02 | $0.00 | Neutralremove | - | -61.06% | AI Analysis | |||||
WSBCPWesBanco | $25.11 | -$0.01 | arrow_drop_down0.04% | $0.00 | 1.38K | 25.11 | $0.00 | Neutralremove | 6.70% | 7.67% | AI Analysis | |||||
WBSWebster Financial | $59.98 | $0.02 | arrow_drop_up0.03% | $10.27B | 5.00 | 59.98 | $0.00 | Neutralremove | 2.66% | 37.19% | AI Analysis | |||||
GLADGladstone Capital | $26.54 | -$0.25 | arrow_drop_down0.93% | $582.80M | 718.00 | 26.82 | $0.00 | Sellkeyboard_arrow_down | - | 32.30% | AI Analysis | |||||
MITAColiseum Acquisition | $11.13 | $11.13 | 0.00% | $73.79M | 5.00 | 11.16 | $0.00 | Neutralremove | - | 3.97% | AI Analysis | |||||
NSTC NSTCNorthern Star Investment Corp. III | $0.07 | $0.00 | 0.00% | $973.14K | 0.00 | 0.00 | $0.00 | Neutralremove | - | -99.26% | AI Analysis | |||||
SYFSynchrony Financial | $63.82 | $0.17 | arrow_drop_up0.27% | $24.78B | 413.00 | 64.00 | $0.00 | Neutralremove | 1.54% | 114.03% | AI Analysis | |||||
OXLCNOxford Lane Capital Corp. - 7.125% Series 2029 Term Preferred Stock | $24.30 | $0.00 | 0.00% | $0.00 | 340.00 | 24.30 | $0.00 | Neutralremove | 7.33% | 6.03% | AI Analysis | |||||
PBBKPB Bankshares | $14.45 | $14.45 | 0.00% | $33.32M | 309.00 | 14.62 | $0.00 | Neutralremove | - | 22.50% | AI Analysis | |||||
PDO PDOPimco Dynamic Income Opportunities Fund | $13.56 | $0.08 | arrow_drop_up0.62% | $1.56B | 20.00 | 13.49 | $0.00 | Neutralremove | - | 12.37% | AI Analysis | |||||
MGRD MGRDMGRD | $17.22 | -$0.07 | arrow_drop_down0.43% | $0.00 | 5.74K | 17.25 | $0.00 | Neutralremove | - | 5.54% | AI Analysis | |||||
 MSMorgan Stanley | $133.19 | $0.95 | arrow_drop_up0.71% | $213.04B | 1.08K | 133.19 | $0.00 | Neutralremove | 2.76% | 67.11% | AI Analysis | |||||
 WFCWells Fargo & Co | $73.71 | $0.28 | arrow_drop_up0.38% | $244.48B | 3.65K | 73.63 | $0.00 | Neutralremove | 2.15% | 72.27% | AI Analysis | |||||
 BACBank of America | $46.57 | $0.16 | arrow_drop_up0.35% | $356.09B | 25.76K | 46.50 | $0.00 | Neutralremove | 2.22% | 55.19% | AI Analysis | |||||
MOFGMidWestOne Financial Group | $32.19 | -$0.00 | arrow_drop_down0.01% | $668.95M | 1.00 | 32.19 | $0.00 | Neutralremove | 3.00% | 48.50% | AI Analysis | |||||
TRSTTrustCo Bank Corp NY | $37.49 | $1.12 | arrow_drop_up3.07% | $691.40M | 6.00 | 36.26 | $0.00 | Neutralremove | 3.93% | 35.53% | AI Analysis | |||||
AVXLAnavex Life Sciences | $8.30 | $0.06 | arrow_drop_up0.78% | $697.44M | 659.00 | 8.31 | $0.00 | Neutralremove | - | 18.64% | AI Analysis | |||||
MCBMetropolitan Bank Holding | $63.25 | $0.00 | 0.00% | $708.24M | 617.00 | 63.25 | $0.00 | Neutralremove | - | 65.35% | AI Analysis | |||||
MLYSMineralys Therapeutics | $12.86 | $0.00 | arrow_drop_up0.03% | $639.48M | 1.00 | 12.86 | $0.00 | Neutralremove | - | 100.07% | AI Analysis |
Showing 3301-3320 of 4977
Results per page:
About Highest EBITDA
Discover the stocks with the highest EBITDA, a significant financial metric indicating a company's operational profitability. EBITDA, or earnings before interest, taxes, depreciation, and amortization, reflects a firm's ability to generate profits from its core operations without factoring in financing and accounting decisions.
Investors seek companies with robust EBITDA figures as it showcases their potential for sustainable growth and cash flow generation. High EBITDA stocks often demonstrate strong financial health and efficiency, making them attractive choices for long-term investment strategies.
Discover the Power of Stocklytics Tools
Our suite of tools empowers you to make informed decisions, seize opportunities, and stay ahead in the competitive trading world.
See Stocklytics Tools